Abstract
The binding of [ 3H]LSD to serotonergic sites in human brain was studied. The pharmacological profile of [ 3H]LSD binding in frontal cortex differed to that in hippocampus. Analysis of the inhibition of [ 3H]LSD binding by serotonin and spiperone was consistent with the presence of two binding sites, which differed in pharmacological specificty. The results are discussed in relation to previously published findings in experimental animals.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
